713 related articles for article (PubMed ID: 28173728)
1. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica.
de Seze J; Blanc F; Kremer S; Collongues N; Fleury M; Marcel C; Namer IJ
J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):409-11. PubMed ID: 20360165
[TBL] [Abstract][Full Text] [Related]
3. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W
PLoS One; 2010 Jul; 5(7):e11625. PubMed ID: 20652023
[TBL] [Abstract][Full Text] [Related]
4. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
[TBL] [Abstract][Full Text] [Related]
5. White matter spectroscopy in neuromyelitis optica: a case control study.
Bichuetti DB; Rivero RL; de Oliveira EM; Oliveira DM; de Souza NA; Nogueira RG; Abdala N; Gabbai A
J Neurol; 2008 Dec; 255(12):1895-9. PubMed ID: 19159058
[TBL] [Abstract][Full Text] [Related]
6. An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue.
Tackley G; Kong Y; Minne R; Messina S; Winkler A; Cavey A; Everett R; DeLuca GC; Weir A; Craner M; Tracey I; Palace J; Stagg CJ; Emir U
Neuroimage; 2021 Sep; 238():118225. PubMed ID: 34062267
[TBL] [Abstract][Full Text] [Related]
7. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
[TBL] [Abstract][Full Text] [Related]
8. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis.
Siger-Zajdel M; Selmaj KW
J Neurol; 2005 Jul; 252(7):830-2. PubMed ID: 15772740
[TBL] [Abstract][Full Text] [Related]
11. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients.
Siger-Zajdel M; Selmaj K
Eur J Neurol; 2006 Mar; 13(3):296-8. PubMed ID: 16618349
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
[TBL] [Abstract][Full Text] [Related]
14. Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging.
Sun J; Song H; Yang Y; Zhang K; Gao X; Li X; Ni L; Lin P; Niu C
Medicine (Baltimore); 2017 Apr; 96(14):e6534. PubMed ID: 28383419
[TBL] [Abstract][Full Text] [Related]
15. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
Sijens PE; Mostert JP; Oudkerk M; De Keyser J
Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
[TBL] [Abstract][Full Text] [Related]
16. Diffuse white matter damage is absent in neuromyelitis optica.
Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W
AJNR Am J Neuroradiol; 2010 Jan; 31(1):76-9. PubMed ID: 19749224
[TBL] [Abstract][Full Text] [Related]
17. Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.
Yetkin MF; Mirza M; Dönmez H
Medicine (Baltimore); 2016 Sep; 95(36):e4782. PubMed ID: 27603381
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of normal appearing white matter in multiple sclerosis: comparison of diffusion magnetic resonance, magnetization transfer imaging and multivoxel magnetic resonance spectroscopy findings with expanded disability status scale.
Anik Y; Demirci A; Efendi H; Bulut SS; Celebi I; Komsuoglu S
Clin Neuroradiol; 2011 Nov; 21(4):207-15. PubMed ID: 21847666
[TBL] [Abstract][Full Text] [Related]
19. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
[TBL] [Abstract][Full Text] [Related]
20. White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study.
Duan Y; Liu Y; Liang P; Jia X; Ye J; Dong H; Li K
Acta Radiol; 2014 Jun; 55(5):589-93. PubMed ID: 23966367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
